FDA Revokes EUAs of Four COVID-19 Monoclonal Antibodies

(MedPage Today) -- The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19.
The four drugs -- bebtelovimab, sotrovimab, casirivimab/imdevimab (REGN-COV2), and tixagevimab/cilgavimab (Evusheld...